| Praxis Precision Medicines, Inc. | 425K | US$124M | 6.5% |
| Revolution Medicines, Inc. | 600K | US$123M | 6.4% |
| IDEAYA Biosciences, Inc. | 2.85M | US$109M | 5.7% |
| Erasca, Inc. | 5.9M | US$86.5M | 4.5% |
| Abivax SA | 870K | US$86.1M | 4.5% |
| CG Oncology, Inc. | 975K | US$69.1M | 3.6% |
| Disc Medicine, Inc. | 1.01M | US$66.4M | 3.5% |
| BioNTech SE | 650K | US$63.9M | 3.3% |
| Tango Therapeutics, Inc. | 2.15M | US$53.6M | 2.8% |
| Madrigal Pharmaceuticals, Inc. | 100K | US$50.4M | 2.6% |
| Enliven Therapeutics, Inc. | 1.08M | US$49.5M | 2.6% |
| Dyne Therapeutics, Inc. | 3M | US$48.3M | 2.5% |
| Achieve Life Sciences, Inc. | 5.95M | US$48.1M | 2.5% |
| Ocular Therapeutix, Inc. | 6M | US$46M | 2.4% |
| Dianthus Therapeutics, Inc. | 500K | US$44M | 2.3% |
| ArriVent BioPharma, Inc. | 1.35M | US$40.9M | 2.1% |
| Cogent Biosciences, Inc. | 1.25M | US$40M | 2.1% |
| Neurocrine Biosciences, Inc. | 250K | US$35.5M | 1.8% |
| Belite Bio, Inc. | 200K | US$34M | 1.8% |
| Axsome Therapeutics, Inc. | 175K | US$32.3M | 1.7% |
| Structure Therapeutics, Inc. | 1M | US$31.3M | 1.6% |
| Olema Pharmaceuticals, Inc. | 3.21M | US$27.7M | 1.4% |
| Maze Therapeutics, Inc. | 935K | US$25.4M | 1.3% |
| Parabilis Medicines, Inc. | 750K | US$24.2M | 1.3% |
| Apnimed, Inc. | 1.1M | US$24.1M | 1.3% |
| Trevi Therapeutics, Inc. | 1.45M | US$20.7M | 1.1% |
| Veradermics, Incorporated | 170K | US$20.6M | 1.1% |
| Vera Therapeutics, Inc. | 600K | US$19.4M | 1.0% |
| Odyssey Therapeutics, Inc. | 846K | US$18.8M | 0.98% |
| Sarepta Therapeutics, Inc. | 1M | US$18.2M | 0.95% |
| Immunocore Holdings plc | 500K | US$15.1M | 0.79% |
| Biohaven Ltd. | 1.1M | US$14.7M | 0.77% |
| Obsidian Therapeutics, Inc. | 1.07M | US$14.6M | 0.76% |
| Definium Therapeutics, Inc. | 350K | US$13.3M | 0.69% |
| Design Therapeutics, Inc. | 1M | US$12.6M | 0.66% |
| Crescent Biopharma, Inc. | 850K | US$12.4M | 0.65% |
| Electra Therapeutics, Inc. | 1M | US$11.3M | 0.59% |
| Minerva Neurosciences, Inc | 3.29M | US$11M | 0.57% |
| LB Pharmaceuticals Inc | 250K | US$9.6M | 0.50% |
| Attovia Therapeutics, Inc. | 391K | US$6.71M | 0.35% |
| Viking Therapeutics, Inc. | 200K | US$6.52M | 0.34% |
| Editas Medicine, Inc. | 2.22M | US$5.71M | 0.30% |
| Tonix Pharmaceuticals Holding Corp. | 550K | US$5.36M | 0.28% |
| Opus Genetics, Inc. | 1M | US$4.84M | 0.25% |
| Vogenx Inc | 205K | US$4.67M | 0.24% |
| Immunovant, Inc. | 85,000 | US$2.87M | 0.15% |
| Jade Biosciences, Inc. | 200K | US$2.81M | 0.15% |
| OnKure Therapeutics, Inc. | 964K | US$2.63M | 0.14% |
| TCGX Acquisition Corp. | 200K | US$2.5M | 0.13% |
| Unicycive Therapeutics, Inc. | 474K | US$2.22M | 0.12% |
| Palatin Technologies, Inc. | 129K | US$1.15M | 0.06% |
| JATT II Acquisition Corp | 100K | US$1.12M | 0.06% |
| JATT III Acquisition Corp | 100K | US$1.1M | 0.06% |
| Research Alliance Corporation III | 100K | US$1.08M | 0.06% |
| Septerna, Inc. | 23,548 | US$921K | 0.05% |
| Amanat Acquisition Corp | 50,000 | US$534K | 0.03% |
| Fractyl Health, Inc. | 505K | US$275K | 0.01% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cybin, Inc. | 0 | US$0 | 0.00% |
| DBV Technologies SA | 0 | US$0 | 0.00% |
| Sensei Biotherapeutics, Inc. | 0 | US$0 | 0.00% |
| Immix Biopharma, Inc. | 0 | US$0 | 0.00% |
| Longeveron Inc. | 0 | US$0 | 0.00% |
| Mineralys Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Q32 Bio Inc. | 0 | US$0 | 0.00% |
| Relay Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Replimune Group, Inc. | 0 | US$0 | 0.00% |
| Rhythm Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Summit Therapeutics Inc. | 0 | US$0 | 0.00% |
| Tenax Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Vor Biopharma Inc. | 0 | US$0 | 0.00% |
| Xenon Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| ACADIA Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Aclaris Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Amylyx Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Annexon, Inc. | 0 | US$0 | 0.00% |
| Arcus Biosciences, Inc. | 0 | US$0 | 0.00% |
| Avalo Therapeutics, Inc. | 0 | US$0 | 0.00% |